Aleman A, Sommer IE, Kahn RS. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J Clin Psychiatry. 2007 Mar;68(3):416-21.
Crespo-Facorro B, Prez-Iglesias R, Ramirez-Bonilla M, Martnez-Garca O, Llorca J, Luis Vzquez-Barquero J. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. J Clin Psychiatry. 2...
Read more »Before you read this, I must confess that I have a relative who works for a major pharmaceutical... Read more »
There's some good news for people diagnosed with schizophrenia. The National Institute on Mental... Read more »
Recently, I was reviewing the literature on tardive dyskinesia, and it struck me how frustrating it... Read more »
...strategies in the search for some biological basis for schizophrenia is to locate abnormalities... Read more »
The U.S. Food and Drug Administration has approved Risperdal for the treatment of schizophrenia and bipolar disorder in children and teens. Risperdal... Read summary »
A new drug called asenapine has shown positive results in a new clinical trial, its maker has reported. According to a news release from drugmaker... Read summary »
The U.S. Food and Drug Administration (FDA) has approved a new drug called Fanapt for the treatment of schizophrenia. FDA officials say Fanapt will... Read summary »
A new schizophrenia treatment that had shown great promise in earlier studies has failed to work better than a currently used medication or a placebo... Read summary »
(Ivanhoe Newswire) -- Even though there have been safety warnings about antipsychotic drugs among the elderly, a new study shows seniors continue to... Read summary »